Dr Savidge assessed the treatment of infants and children throughout the late 1970s and early 1980s stating "The lack of consideration and disregard of the then current therapeutic recommendations for the treatment of children under the age of 4 years regarding the use of cryoprecipitate in this case was negligent...The overwhelming use of commercial U.S. concentrates in preference to cryoprecipitate or NHS factor VIII is remarkable,"

Chronology Information

Date:

Chapter/issue
Haemophilia Centres: Policies and Practice
Key Person(s)
Professor Geoffrey F Savidge